nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—CYP1A2—Dacarbazine—pancreatic cancer	0.0582	0.153	CbGbCtD
Alitretinoin—CYP1A2—Tamoxifen—pancreatic cancer	0.0463	0.121	CbGbCtD
Alitretinoin—ABCB1—Tamoxifen—pancreatic cancer	0.0405	0.106	CbGbCtD
Alitretinoin—CYP1A2—Erlotinib—pancreatic cancer	0.0394	0.103	CbGbCtD
Alitretinoin—ABCB1—Gemcitabine—pancreatic cancer	0.0349	0.0915	CbGbCtD
Alitretinoin—ABCB1—Erlotinib—pancreatic cancer	0.0344	0.0903	CbGbCtD
Alitretinoin—CYP1A2—Fluorouracil—pancreatic cancer	0.0341	0.0895	CbGbCtD
Alitretinoin—ABCB1—Irinotecan—pancreatic cancer	0.0311	0.0815	CbGbCtD
Alitretinoin—ABCB1—Docetaxel—pancreatic cancer	0.0228	0.0598	CbGbCtD
Alitretinoin—ABCB1—Sunitinib—pancreatic cancer	0.0227	0.0595	CbGbCtD
Alitretinoin—ABCB1—Doxorubicin—pancreatic cancer	0.017	0.0445	CbGbCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—pancreatic cancer	0.000131	0.000779	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000131	0.000779	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000131	0.000779	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—EZH2—pancreatic cancer	0.000131	0.000778	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.00013	0.000775	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	0.00013	0.000773	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	0.00013	0.000773	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	0.000129	0.000766	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000128	0.000763	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—EZH2—pancreatic cancer	0.000128	0.000763	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—NOTCH3—pancreatic cancer	0.000128	0.000761	CbGpPWpGaD
Alitretinoin—Conjunctivitis—Epirubicin—pancreatic cancer	0.000128	0.000283	CcSEcCtD
Alitretinoin—Urinary tract infection—Epirubicin—pancreatic cancer	0.000128	0.000283	CcSEcCtD
Alitretinoin—Neutropenia—Doxorubicin—pancreatic cancer	0.000127	0.000283	CcSEcCtD
Alitretinoin—Dysuria—Doxorubicin—pancreatic cancer	0.000127	0.000283	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	0.000127	0.000759	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000127	0.000281	CcSEcCtD
Alitretinoin—Dry mouth—Docetaxel—pancreatic cancer	0.000127	0.000281	CcSEcCtD
Alitretinoin—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000127	0.000281	CcSEcCtD
Alitretinoin—Sweating—Epirubicin—pancreatic cancer	0.000126	0.000279	CcSEcCtD
Alitretinoin—Pollakiuria—Doxorubicin—pancreatic cancer	0.000126	0.000279	CcSEcCtD
Alitretinoin—Asthenia—Gemcitabine—pancreatic cancer	0.000126	0.000279	CcSEcCtD
Alitretinoin—RARB—Gene Expression—NOTCH3—pancreatic cancer	0.000125	0.000746	CbGpPWpGaD
Alitretinoin—Haematuria—Epirubicin—pancreatic cancer	0.000125	0.000278	CcSEcCtD
Alitretinoin—Confusional state—Docetaxel—pancreatic cancer	0.000125	0.000278	CcSEcCtD
Alitretinoin—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000124	0.000276	CcSEcCtD
Alitretinoin—Oedema—Docetaxel—pancreatic cancer	0.000124	0.000276	CcSEcCtD
Alitretinoin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000124	0.000276	CcSEcCtD
Alitretinoin—Weight increased—Doxorubicin—pancreatic cancer	0.000124	0.000275	CcSEcCtD
Alitretinoin—Epistaxis—Epirubicin—pancreatic cancer	0.000124	0.000275	CcSEcCtD
Alitretinoin—Pruritus—Gemcitabine—pancreatic cancer	0.000124	0.000275	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	0.000124	0.000738	CbGpPWpGaD
Alitretinoin—Infection—Docetaxel—pancreatic cancer	0.000123	0.000274	CcSEcCtD
Alitretinoin—Weight decreased—Doxorubicin—pancreatic cancer	0.000123	0.000274	CcSEcCtD
Alitretinoin—Sinusitis—Epirubicin—pancreatic cancer	0.000123	0.000273	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	0.000123	0.000734	CbGpPWpGaD
Alitretinoin—Diarrhoea—Irinotecan—pancreatic cancer	0.000123	0.000273	CcSEcCtD
Alitretinoin—RARA—Gene Expression—EZH2—pancreatic cancer	0.000123	0.000731	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—EZH2—pancreatic cancer	0.000123	0.000731	CbGpPWpGaD
Alitretinoin—Agranulocytosis—Epirubicin—pancreatic cancer	0.000123	0.000272	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.000122	0.000728	CbGpPWpGaD
Alitretinoin—Pneumonia—Doxorubicin—pancreatic cancer	0.000122	0.000271	CcSEcCtD
Alitretinoin—Shock—Docetaxel—pancreatic cancer	0.000122	0.000271	CcSEcCtD
Alitretinoin—Nervous system disorder—Docetaxel—pancreatic cancer	0.000122	0.00027	CcSEcCtD
Alitretinoin—Pruritus—Fluorouracil—pancreatic cancer	0.000122	0.00027	CcSEcCtD
Alitretinoin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000122	0.00027	CcSEcCtD
Alitretinoin—Drowsiness—Doxorubicin—pancreatic cancer	0.000122	0.00027	CcSEcCtD
Alitretinoin—Infestation NOS—Doxorubicin—pancreatic cancer	0.000122	0.00027	CcSEcCtD
Alitretinoin—Infestation—Doxorubicin—pancreatic cancer	0.000122	0.00027	CcSEcCtD
Alitretinoin—Tachycardia—Docetaxel—pancreatic cancer	0.000121	0.000269	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—HSPA1A—pancreatic cancer	0.000121	0.000721	CbGpPWpGaD
Alitretinoin—Skin disorder—Docetaxel—pancreatic cancer	0.000121	0.000268	CcSEcCtD
Alitretinoin—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000121	0.000267	CcSEcCtD
Alitretinoin—RARA—Gene Expression—NOTCH3—pancreatic cancer	0.00012	0.000716	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—NOTCH3—pancreatic cancer	0.00012	0.000716	CbGpPWpGaD
Alitretinoin—Diarrhoea—Gemcitabine—pancreatic cancer	0.00012	0.000266	CcSEcCtD
Alitretinoin—Renal failure—Doxorubicin—pancreatic cancer	0.00012	0.000265	CcSEcCtD
Alitretinoin—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000119	0.000264	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—TYMS—pancreatic cancer	0.000119	0.000709	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—TYMS—pancreatic cancer	0.000119	0.000709	CbGpPWpGaD
Alitretinoin—Dizziness—Irinotecan—pancreatic cancer	0.000119	0.000264	CcSEcCtD
Alitretinoin—RARB—Gene Expression—HSPA1A—pancreatic cancer	0.000119	0.000707	CbGpPWpGaD
Alitretinoin—Haemoglobin—Epirubicin—pancreatic cancer	0.000119	0.000263	CcSEcCtD
Alitretinoin—Stomatitis—Doxorubicin—pancreatic cancer	0.000119	0.000263	CcSEcCtD
Alitretinoin—Anorexia—Docetaxel—pancreatic cancer	0.000118	0.000263	CcSEcCtD
Alitretinoin—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000118	0.000262	CcSEcCtD
Alitretinoin—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000118	0.000262	CcSEcCtD
Alitretinoin—Haemorrhage—Epirubicin—pancreatic cancer	0.000118	0.000262	CcSEcCtD
Alitretinoin—Hepatitis—Epirubicin—pancreatic cancer	0.000118	0.000262	CcSEcCtD
Alitretinoin—Diarrhoea—Fluorouracil—pancreatic cancer	0.000118	0.000261	CcSEcCtD
Alitretinoin—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000117	0.00026	CcSEcCtD
Alitretinoin—Pharyngitis—Epirubicin—pancreatic cancer	0.000117	0.00026	CcSEcCtD
Alitretinoin—Sweating—Doxorubicin—pancreatic cancer	0.000117	0.000258	CcSEcCtD
Alitretinoin—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000116	0.000258	CcSEcCtD
Alitretinoin—Oedema peripheral—Epirubicin—pancreatic cancer	0.000116	0.000258	CcSEcCtD
Alitretinoin—Hypotension—Docetaxel—pancreatic cancer	0.000116	0.000257	CcSEcCtD
Alitretinoin—Haematuria—Doxorubicin—pancreatic cancer	0.000116	0.000257	CcSEcCtD
Alitretinoin—Urethral disorder—Epirubicin—pancreatic cancer	0.000116	0.000256	CcSEcCtD
Alitretinoin—Epistaxis—Doxorubicin—pancreatic cancer	0.000115	0.000254	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—STAT3—pancreatic cancer	0.000115	0.000682	CbGpPWpGaD
Alitretinoin—Vomiting—Irinotecan—pancreatic cancer	0.000114	0.000253	CcSEcCtD
Alitretinoin—Sinusitis—Doxorubicin—pancreatic cancer	0.000114	0.000253	CcSEcCtD
Alitretinoin—Dizziness—Fluorouracil—pancreatic cancer	0.000114	0.000252	CcSEcCtD
Alitretinoin—RARA—Gene Expression—HSPA1A—pancreatic cancer	0.000114	0.000678	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—HSPA1A—pancreatic cancer	0.000114	0.000678	CbGpPWpGaD
Alitretinoin—Visual impairment—Epirubicin—pancreatic cancer	0.000114	0.000252	CcSEcCtD
Alitretinoin—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000113	0.000252	CcSEcCtD
Alitretinoin—Rash—Irinotecan—pancreatic cancer	0.000113	0.000251	CcSEcCtD
Alitretinoin—Dermatitis—Irinotecan—pancreatic cancer	0.000113	0.000251	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000113	0.000251	CcSEcCtD
Alitretinoin—Headache—Irinotecan—pancreatic cancer	0.000113	0.00025	CcSEcCtD
Alitretinoin—Insomnia—Docetaxel—pancreatic cancer	0.000112	0.000249	CcSEcCtD
Alitretinoin—Paraesthesia—Docetaxel—pancreatic cancer	0.000112	0.000247	CcSEcCtD
Alitretinoin—Erythema multiforme—Epirubicin—pancreatic cancer	0.000112	0.000247	CcSEcCtD
Alitretinoin—Vomiting—Gemcitabine—pancreatic cancer	0.000111	0.000247	CcSEcCtD
Alitretinoin—Dyspnoea—Docetaxel—pancreatic cancer	0.000111	0.000246	CcSEcCtD
Alitretinoin—Somnolence—Docetaxel—pancreatic cancer	0.00011	0.000245	CcSEcCtD
Alitretinoin—Rash—Gemcitabine—pancreatic cancer	0.00011	0.000245	CcSEcCtD
Alitretinoin—Dermatitis—Gemcitabine—pancreatic cancer	0.00011	0.000245	CcSEcCtD
Alitretinoin—Eye disorder—Epirubicin—pancreatic cancer	0.00011	0.000244	CcSEcCtD
Alitretinoin—Tinnitus—Epirubicin—pancreatic cancer	0.00011	0.000244	CcSEcCtD
Alitretinoin—Haemoglobin—Doxorubicin—pancreatic cancer	0.00011	0.000243	CcSEcCtD
Alitretinoin—Headache—Gemcitabine—pancreatic cancer	0.00011	0.000243	CcSEcCtD
Alitretinoin—Flushing—Epirubicin—pancreatic cancer	0.000109	0.000243	CcSEcCtD
Alitretinoin—Vomiting—Fluorouracil—pancreatic cancer	0.000109	0.000243	CcSEcCtD
Alitretinoin—Dyspepsia—Docetaxel—pancreatic cancer	0.000109	0.000243	CcSEcCtD
Alitretinoin—Hepatitis—Doxorubicin—pancreatic cancer	0.000109	0.000242	CcSEcCtD
Alitretinoin—Haemorrhage—Doxorubicin—pancreatic cancer	0.000109	0.000242	CcSEcCtD
Alitretinoin—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000109	0.000241	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	0.000109	0.000647	CbGpPWpGaD
Alitretinoin—Rash—Fluorouracil—pancreatic cancer	0.000109	0.000241	CcSEcCtD
Alitretinoin—Dermatitis—Fluorouracil—pancreatic cancer	0.000108	0.00024	CcSEcCtD
Alitretinoin—Pharyngitis—Doxorubicin—pancreatic cancer	0.000108	0.00024	CcSEcCtD
Alitretinoin—Decreased appetite—Docetaxel—pancreatic cancer	0.000108	0.00024	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	0.000108	0.000643	CbGpPWpGaD
Alitretinoin—Headache—Fluorouracil—pancreatic cancer	0.000108	0.000239	CcSEcCtD
Alitretinoin—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000108	0.000239	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—pancreatic cancer	0.000108	0.000641	CbGpPWpGaD
Alitretinoin—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000108	0.000238	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000107	0.000238	CcSEcCtD
Alitretinoin—Fatigue—Docetaxel—pancreatic cancer	0.000107	0.000238	CcSEcCtD
Alitretinoin—Angiopathy—Epirubicin—pancreatic cancer	0.000107	0.000237	CcSEcCtD
Alitretinoin—Urethral disorder—Doxorubicin—pancreatic cancer	0.000107	0.000237	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	0.000107	0.000637	CbGpPWpGaD
Alitretinoin—Nausea—Irinotecan—pancreatic cancer	0.000107	0.000237	CcSEcCtD
Alitretinoin—Constipation—Docetaxel—pancreatic cancer	0.000106	0.000236	CcSEcCtD
Alitretinoin—Pain—Docetaxel—pancreatic cancer	0.000106	0.000236	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—TGFB1—pancreatic cancer	0.000106	0.000632	CbGpPWpGaD
Alitretinoin—Chills—Epirubicin—pancreatic cancer	0.000106	0.000235	CcSEcCtD
Alitretinoin—Arrhythmia—Epirubicin—pancreatic cancer	0.000105	0.000234	CcSEcCtD
Alitretinoin—RARG—Gene Expression—SMAD4—pancreatic cancer	0.000105	0.000627	CbGpPWpGaD
Alitretinoin—Visual impairment—Doxorubicin—pancreatic cancer	0.000105	0.000233	CcSEcCtD
Alitretinoin—RXRA—Metabolism—PRSS1—pancreatic cancer	0.000105	0.000626	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	0.000105	0.000626	CbGpPWpGaD
Alitretinoin—Alopecia—Epirubicin—pancreatic cancer	0.000104	0.000231	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	0.000104	0.00062	CbGpPWpGaD
Alitretinoin—Nausea—Gemcitabine—pancreatic cancer	0.000104	0.000231	CcSEcCtD
Alitretinoin—Mental disorder—Epirubicin—pancreatic cancer	0.000103	0.000229	CcSEcCtD
Alitretinoin—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000103	0.000229	CcSEcCtD
Alitretinoin—Erythema—Epirubicin—pancreatic cancer	0.000103	0.000228	CcSEcCtD
Alitretinoin—Malnutrition—Epirubicin—pancreatic cancer	0.000103	0.000228	CcSEcCtD
Alitretinoin—Feeling abnormal—Docetaxel—pancreatic cancer	0.000102	0.000227	CcSEcCtD
Alitretinoin—Nausea—Fluorouracil—pancreatic cancer	0.000102	0.000227	CcSEcCtD
Alitretinoin—Eye disorder—Doxorubicin—pancreatic cancer	0.000102	0.000226	CcSEcCtD
Alitretinoin—Tinnitus—Doxorubicin—pancreatic cancer	0.000102	0.000226	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000102	0.000225	CcSEcCtD
Alitretinoin—Flushing—Doxorubicin—pancreatic cancer	0.000101	0.000225	CcSEcCtD
Alitretinoin—Flatulence—Epirubicin—pancreatic cancer	0.000101	0.000224	CcSEcCtD
Alitretinoin—Tension—Epirubicin—pancreatic cancer	0.000101	0.000223	CcSEcCtD
Alitretinoin—CYP1A2—Arachidonic acid metabolism—PTGS2—pancreatic cancer	0.000101	0.000599	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	0.0001	0.000597	CbGpPWpGaD
Alitretinoin—Nervousness—Epirubicin—pancreatic cancer	9.97e-05	0.000221	CcSEcCtD
Alitretinoin—Back pain—Epirubicin—pancreatic cancer	9.93e-05	0.00022	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—TNF—pancreatic cancer	9.91e-05	0.00059	CbGpPWpGaD
Alitretinoin—Angiopathy—Doxorubicin—pancreatic cancer	9.9e-05	0.00022	CcSEcCtD
Alitretinoin—Body temperature increased—Docetaxel—pancreatic cancer	9.82e-05	0.000218	CcSEcCtD
Alitretinoin—Abdominal pain—Docetaxel—pancreatic cancer	9.82e-05	0.000218	CcSEcCtD
Alitretinoin—RXRA—Generic Transcription Pathway—SMAD4—pancreatic cancer	9.8e-05	0.000583	CbGpPWpGaD
Alitretinoin—Chills—Doxorubicin—pancreatic cancer	9.79e-05	0.000217	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	9.75e-05	0.000581	CbGpPWpGaD
Alitretinoin—Arrhythmia—Doxorubicin—pancreatic cancer	9.75e-05	0.000216	CcSEcCtD
Alitretinoin—Vision blurred—Epirubicin—pancreatic cancer	9.68e-05	0.000215	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—APOE—pancreatic cancer	9.68e-05	0.000576	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—APOE—pancreatic cancer	9.68e-05	0.000576	CbGpPWpGaD
Alitretinoin—RXRA—NRF2 pathway—TGFB1—pancreatic cancer	9.67e-05	0.000576	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	9.66e-05	0.000575	CbGpPWpGaD
Alitretinoin—Alopecia—Doxorubicin—pancreatic cancer	9.64e-05	0.000214	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—SMAD4—pancreatic cancer	9.62e-05	0.000573	CbGpPWpGaD
Alitretinoin—Mental disorder—Doxorubicin—pancreatic cancer	9.56e-05	0.000212	CcSEcCtD
Alitretinoin—Ill-defined disorder—Epirubicin—pancreatic cancer	9.53e-05	0.000211	CcSEcCtD
Alitretinoin—Erythema—Doxorubicin—pancreatic cancer	9.5e-05	0.000211	CcSEcCtD
Alitretinoin—Malnutrition—Doxorubicin—pancreatic cancer	9.5e-05	0.000211	CcSEcCtD
Alitretinoin—Anaemia—Epirubicin—pancreatic cancer	9.49e-05	0.00021	CcSEcCtD
Alitretinoin—RARB—Gene Expression—SMAD4—pancreatic cancer	9.44e-05	0.000562	CbGpPWpGaD
Alitretinoin—Agitation—Epirubicin—pancreatic cancer	9.44e-05	0.000209	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	9.41e-05	0.000561	CbGpPWpGaD
Alitretinoin—Flatulence—Doxorubicin—pancreatic cancer	9.36e-05	0.000208	CcSEcCtD
Alitretinoin—Tension—Doxorubicin—pancreatic cancer	9.32e-05	0.000207	CcSEcCtD
Alitretinoin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—pancreatic cancer	9.28e-05	0.000553	CbGpPWpGaD
Alitretinoin—Malaise—Epirubicin—pancreatic cancer	9.26e-05	0.000205	CcSEcCtD
Alitretinoin—Nervousness—Doxorubicin—pancreatic cancer	9.23e-05	0.000205	CcSEcCtD
Alitretinoin—RXRA—Developmental Biology—SMAD4—pancreatic cancer	9.22e-05	0.000549	CbGpPWpGaD
Alitretinoin—Syncope—Epirubicin—pancreatic cancer	9.21e-05	0.000204	CcSEcCtD
Alitretinoin—Back pain—Doxorubicin—pancreatic cancer	9.19e-05	0.000204	CcSEcCtD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	9.16e-05	0.000546	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	9.16e-05	0.000546	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Docetaxel—pancreatic cancer	9.15e-05	0.000203	CcSEcCtD
Alitretinoin—RXRA—Metabolism—ARG2—pancreatic cancer	9.12e-05	0.000543	CbGpPWpGaD
Alitretinoin—Palpitations—Epirubicin—pancreatic cancer	9.07e-05	0.000201	CcSEcCtD
Alitretinoin—RARA—Gene Expression—SMAD4—pancreatic cancer	9.05e-05	0.000539	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—SMAD4—pancreatic cancer	9.05e-05	0.000539	CbGpPWpGaD
Alitretinoin—Loss of consciousness—Epirubicin—pancreatic cancer	9.02e-05	0.0002	CcSEcCtD
Alitretinoin—RXRA—Developmental Biology—HES1—pancreatic cancer	9e-05	0.000536	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	9e-05	0.000536	CbGpPWpGaD
Alitretinoin—Cough—Epirubicin—pancreatic cancer	8.96e-05	0.000199	CcSEcCtD
Alitretinoin—Vision blurred—Doxorubicin—pancreatic cancer	8.95e-05	0.000199	CcSEcCtD
Alitretinoin—Asthenia—Docetaxel—pancreatic cancer	8.91e-05	0.000198	CcSEcCtD
Alitretinoin—Convulsion—Epirubicin—pancreatic cancer	8.9e-05	0.000197	CcSEcCtD
Alitretinoin—Hypertension—Epirubicin—pancreatic cancer	8.86e-05	0.000197	CcSEcCtD
Alitretinoin—Ill-defined disorder—Doxorubicin—pancreatic cancer	8.81e-05	0.000196	CcSEcCtD
Alitretinoin—Pruritus—Docetaxel—pancreatic cancer	8.79e-05	0.000195	CcSEcCtD
Alitretinoin—Anaemia—Doxorubicin—pancreatic cancer	8.78e-05	0.000195	CcSEcCtD
Alitretinoin—Myalgia—Epirubicin—pancreatic cancer	8.74e-05	0.000194	CcSEcCtD
Alitretinoin—Arthralgia—Epirubicin—pancreatic cancer	8.74e-05	0.000194	CcSEcCtD
Alitretinoin—Chest pain—Epirubicin—pancreatic cancer	8.74e-05	0.000194	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—PIK3CG—pancreatic cancer	8.73e-05	0.00052	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PIK3CG—pancreatic cancer	8.73e-05	0.00052	CbGpPWpGaD
Alitretinoin—Agitation—Doxorubicin—pancreatic cancer	8.73e-05	0.000194	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	8.73e-05	0.00052	CbGpPWpGaD
Alitretinoin—Anxiety—Epirubicin—pancreatic cancer	8.71e-05	0.000193	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—pancreatic cancer	8.7e-05	0.000518	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—pancreatic cancer	8.7e-05	0.000518	CbGpPWpGaD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	8.68e-05	0.000193	CcSEcCtD
Alitretinoin—RARG—Generic Transcription Pathway—MYC—pancreatic cancer	8.67e-05	0.000516	CbGpPWpGaD
Alitretinoin—Discomfort—Epirubicin—pancreatic cancer	8.64e-05	0.000192	CcSEcCtD
Alitretinoin—Malaise—Doxorubicin—pancreatic cancer	8.57e-05	0.00019	CcSEcCtD
Alitretinoin—Dry mouth—Epirubicin—pancreatic cancer	8.55e-05	0.00019	CcSEcCtD
Alitretinoin—Syncope—Doxorubicin—pancreatic cancer	8.52e-05	0.000189	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	8.5e-05	0.000506	CbGpPWpGaD
Alitretinoin—Diarrhoea—Docetaxel—pancreatic cancer	8.5e-05	0.000189	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—CXCL8—pancreatic cancer	8.48e-05	0.000505	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—pancreatic cancer	8.47e-05	0.000505	CbGpPWpGaD
Alitretinoin—Confusional state—Epirubicin—pancreatic cancer	8.45e-05	0.000187	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—PPARG—pancreatic cancer	8.43e-05	0.000502	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PPARG—pancreatic cancer	8.43e-05	0.000502	CbGpPWpGaD
Alitretinoin—Palpitations—Doxorubicin—pancreatic cancer	8.4e-05	0.000186	CcSEcCtD
Alitretinoin—Anaphylactic shock—Epirubicin—pancreatic cancer	8.38e-05	0.000186	CcSEcCtD
Alitretinoin—Oedema—Epirubicin—pancreatic cancer	8.38e-05	0.000186	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—pancreatic cancer	8.37e-05	0.000498	CbGpPWpGaD
Alitretinoin—Loss of consciousness—Doxorubicin—pancreatic cancer	8.35e-05	0.000185	CcSEcCtD
Alitretinoin—Infection—Epirubicin—pancreatic cancer	8.33e-05	0.000185	CcSEcCtD
Alitretinoin—Cough—Doxorubicin—pancreatic cancer	8.29e-05	0.000184	CcSEcCtD
Alitretinoin—Shock—Epirubicin—pancreatic cancer	8.24e-05	0.000183	CcSEcCtD
Alitretinoin—Convulsion—Doxorubicin—pancreatic cancer	8.23e-05	0.000183	CcSEcCtD
Alitretinoin—Nervous system disorder—Epirubicin—pancreatic cancer	8.22e-05	0.000182	CcSEcCtD
Alitretinoin—Dizziness—Docetaxel—pancreatic cancer	8.22e-05	0.000182	CcSEcCtD
Alitretinoin—Thrombocytopenia—Epirubicin—pancreatic cancer	8.2e-05	0.000182	CcSEcCtD
Alitretinoin—Hypertension—Doxorubicin—pancreatic cancer	8.2e-05	0.000182	CcSEcCtD
Alitretinoin—Tachycardia—Epirubicin—pancreatic cancer	8.18e-05	0.000181	CcSEcCtD
Alitretinoin—Skin disorder—Epirubicin—pancreatic cancer	8.14e-05	0.000181	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	8.14e-05	0.000485	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CASP3—pancreatic cancer	8.11e-05	0.000483	CbGpPWpGaD
Alitretinoin—Hyperhidrosis—Epirubicin—pancreatic cancer	8.1e-05	0.00018	CcSEcCtD
Alitretinoin—Arthralgia—Doxorubicin—pancreatic cancer	8.09e-05	0.000179	CcSEcCtD
Alitretinoin—Chest pain—Doxorubicin—pancreatic cancer	8.09e-05	0.000179	CcSEcCtD
Alitretinoin—Myalgia—Doxorubicin—pancreatic cancer	8.09e-05	0.000179	CcSEcCtD
Alitretinoin—Anxiety—Doxorubicin—pancreatic cancer	8.06e-05	0.000179	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	8.03e-05	0.000178	CcSEcCtD
Alitretinoin—Discomfort—Doxorubicin—pancreatic cancer	7.99e-05	0.000177	CcSEcCtD
Alitretinoin—Anorexia—Epirubicin—pancreatic cancer	7.99e-05	0.000177	CcSEcCtD
Alitretinoin—RXRA—Metabolism—TYMP—pancreatic cancer	7.97e-05	0.000475	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	7.95e-05	0.000473	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—MYC—pancreatic cancer	7.93e-05	0.000472	CbGpPWpGaD
Alitretinoin—Dry mouth—Doxorubicin—pancreatic cancer	7.91e-05	0.000175	CcSEcCtD
Alitretinoin—Vomiting—Docetaxel—pancreatic cancer	7.9e-05	0.000175	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	7.88e-05	0.000469	CbGpPWpGaD
Alitretinoin—Rash—Docetaxel—pancreatic cancer	7.83e-05	0.000174	CcSEcCtD
Alitretinoin—Hypotension—Epirubicin—pancreatic cancer	7.83e-05	0.000174	CcSEcCtD
Alitretinoin—Dermatitis—Docetaxel—pancreatic cancer	7.83e-05	0.000174	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	7.82e-05	0.000466	CbGpPWpGaD
Alitretinoin—Confusional state—Doxorubicin—pancreatic cancer	7.82e-05	0.000173	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	7.8e-05	0.000465	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—pancreatic cancer	7.79e-05	0.000464	CbGpPWpGaD
Alitretinoin—Headache—Docetaxel—pancreatic cancer	7.78e-05	0.000173	CcSEcCtD
Alitretinoin—RARB—Generic Transcription Pathway—MYC—pancreatic cancer	7.78e-05	0.000463	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatic cancer	7.77e-05	0.000463	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—MEN1—pancreatic cancer	7.77e-05	0.000463	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—NOTCH1—pancreatic cancer	7.76e-05	0.000462	CbGpPWpGaD
Alitretinoin—Oedema—Doxorubicin—pancreatic cancer	7.75e-05	0.000172	CcSEcCtD
Alitretinoin—Anaphylactic shock—Doxorubicin—pancreatic cancer	7.75e-05	0.000172	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	7.74e-05	0.000461	CbGpPWpGaD
Alitretinoin—Infection—Doxorubicin—pancreatic cancer	7.7e-05	0.000171	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—PIK3CD—pancreatic cancer	7.68e-05	0.000457	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PIK3CD—pancreatic cancer	7.68e-05	0.000457	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	7.65e-05	0.000456	CbGpPWpGaD
Alitretinoin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	7.63e-05	0.000169	CcSEcCtD
Alitretinoin—Shock—Doxorubicin—pancreatic cancer	7.63e-05	0.000169	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pancreatic cancer	7.62e-05	0.000454	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pancreatic cancer	7.62e-05	0.000454	CbGpPWpGaD
Alitretinoin—Nervous system disorder—Doxorubicin—pancreatic cancer	7.6e-05	0.000169	CcSEcCtD
Alitretinoin—Thrombocytopenia—Doxorubicin—pancreatic cancer	7.59e-05	0.000168	CcSEcCtD
Alitretinoin—Insomnia—Epirubicin—pancreatic cancer	7.58e-05	0.000168	CcSEcCtD
Alitretinoin—Tachycardia—Doxorubicin—pancreatic cancer	7.57e-05	0.000168	CcSEcCtD
Alitretinoin—Skin disorder—Doxorubicin—pancreatic cancer	7.53e-05	0.000167	CcSEcCtD
Alitretinoin—Paraesthesia—Epirubicin—pancreatic cancer	7.52e-05	0.000167	CcSEcCtD
Alitretinoin—Hyperhidrosis—Doxorubicin—pancreatic cancer	7.5e-05	0.000166	CcSEcCtD
Alitretinoin—Dyspnoea—Epirubicin—pancreatic cancer	7.47e-05	0.000166	CcSEcCtD
Alitretinoin—RARA—Generic Transcription Pathway—MYC—pancreatic cancer	7.46e-05	0.000444	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—MYC—pancreatic cancer	7.46e-05	0.000444	CbGpPWpGaD
Alitretinoin—Somnolence—Epirubicin—pancreatic cancer	7.45e-05	0.000165	CcSEcCtD
Alitretinoin—Anorexia—Doxorubicin—pancreatic cancer	7.39e-05	0.000164	CcSEcCtD
Alitretinoin—Nausea—Docetaxel—pancreatic cancer	7.38e-05	0.000164	CcSEcCtD
Alitretinoin—Dyspepsia—Epirubicin—pancreatic cancer	7.38e-05	0.000164	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—NOTCH4—pancreatic cancer	7.36e-05	0.000439	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—PPARG—pancreatic cancer	7.32e-05	0.000436	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	7.29e-05	0.000434	CbGpPWpGaD
Alitretinoin—Decreased appetite—Epirubicin—pancreatic cancer	7.28e-05	0.000162	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatic cancer	7.26e-05	0.000432	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	7.26e-05	0.000432	CbGpPWpGaD
Alitretinoin—Hypotension—Doxorubicin—pancreatic cancer	7.25e-05	0.000161	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	7.23e-05	0.00016	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	7.23e-05	0.00043	CbGpPWpGaD
Alitretinoin—Fatigue—Epirubicin—pancreatic cancer	7.22e-05	0.00016	CcSEcCtD
Alitretinoin—RXRA—Generic Transcription Pathway—NOTCH1—pancreatic cancer	7.22e-05	0.00043	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—KDR—pancreatic cancer	7.21e-05	0.00043	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	7.2e-05	0.000429	CbGpPWpGaD
Alitretinoin—Pain—Epirubicin—pancreatic cancer	7.17e-05	0.000159	CcSEcCtD
Alitretinoin—Constipation—Epirubicin—pancreatic cancer	7.17e-05	0.000159	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—NOTCH1—pancreatic cancer	7.09e-05	0.000423	CbGpPWpGaD
Alitretinoin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	7.06e-05	0.000157	CcSEcCtD
Alitretinoin—RXRA—Developmental Biology—MET—pancreatic cancer	7.06e-05	0.000421	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—HSPA1B—pancreatic cancer	7.03e-05	0.000418	CbGpPWpGaD
Alitretinoin—Insomnia—Doxorubicin—pancreatic cancer	7.01e-05	0.000156	CcSEcCtD
Alitretinoin—Paraesthesia—Doxorubicin—pancreatic cancer	6.96e-05	0.000154	CcSEcCtD
Alitretinoin—RARB—Gene Expression—NOTCH1—pancreatic cancer	6.96e-05	0.000414	CbGpPWpGaD
Alitretinoin—Dyspnoea—Doxorubicin—pancreatic cancer	6.91e-05	0.000153	CcSEcCtD
Alitretinoin—Feeling abnormal—Epirubicin—pancreatic cancer	6.91e-05	0.000153	CcSEcCtD
Alitretinoin—Somnolence—Doxorubicin—pancreatic cancer	6.89e-05	0.000153	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	6.88e-05	0.00041	CbGpPWpGaD
Alitretinoin—Gastrointestinal pain—Epirubicin—pancreatic cancer	6.85e-05	0.000152	CcSEcCtD
Alitretinoin—Dyspepsia—Doxorubicin—pancreatic cancer	6.83e-05	0.000151	CcSEcCtD
Alitretinoin—RXRA—Generic Transcription Pathway—PPARG—pancreatic cancer	6.81e-05	0.000406	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—NOTCH1—pancreatic cancer	6.8e-05	0.000405	CbGpPWpGaD
Alitretinoin—Decreased appetite—Doxorubicin—pancreatic cancer	6.74e-05	0.000149	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—PPARG—pancreatic cancer	6.7e-05	0.000399	CbGpPWpGaD
Alitretinoin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	6.69e-05	0.000148	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—PIK3CB—pancreatic cancer	6.69e-05	0.000399	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PIK3CB—pancreatic cancer	6.69e-05	0.000399	CbGpPWpGaD
Alitretinoin—Fatigue—Doxorubicin—pancreatic cancer	6.68e-05	0.000148	CcSEcCtD
Alitretinoin—RXRB—Gene Expression—NOTCH1—pancreatic cancer	6.67e-05	0.000397	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—NOTCH1—pancreatic cancer	6.67e-05	0.000397	CbGpPWpGaD
Alitretinoin—Urticaria—Epirubicin—pancreatic cancer	6.66e-05	0.000148	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	6.64e-05	0.000395	CbGpPWpGaD
Alitretinoin—Pain—Doxorubicin—pancreatic cancer	6.63e-05	0.000147	CcSEcCtD
Alitretinoin—Constipation—Doxorubicin—pancreatic cancer	6.63e-05	0.000147	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—PTGS2—pancreatic cancer	6.63e-05	0.000395	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PTGS2—pancreatic cancer	6.63e-05	0.000395	CbGpPWpGaD
Alitretinoin—Body temperature increased—Epirubicin—pancreatic cancer	6.62e-05	0.000147	CcSEcCtD
Alitretinoin—Abdominal pain—Epirubicin—pancreatic cancer	6.62e-05	0.000147	CcSEcCtD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	6.58e-05	0.000392	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—PPARG—pancreatic cancer	6.57e-05	0.000391	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GLP1R—pancreatic cancer	6.42e-05	0.000383	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	6.42e-05	0.000383	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—PPARG—pancreatic cancer	6.41e-05	0.000382	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—EZH2—pancreatic cancer	6.4e-05	0.000381	CbGpPWpGaD
Alitretinoin—Feeling abnormal—Doxorubicin—pancreatic cancer	6.39e-05	0.000142	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	6.34e-05	0.000141	CcSEcCtD
Alitretinoin—RXRA—Metabolism—DPYD—pancreatic cancer	6.32e-05	0.000376	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	6.32e-05	0.000376	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—PPARG—pancreatic cancer	6.3e-05	0.000375	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—PPARG—pancreatic cancer	6.3e-05	0.000375	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—NOTCH3—pancreatic cancer	6.26e-05	0.000373	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Epirubicin—pancreatic cancer	6.17e-05	0.000137	CcSEcCtD
Alitretinoin—Urticaria—Doxorubicin—pancreatic cancer	6.16e-05	0.000137	CcSEcCtD
Alitretinoin—Body temperature increased—Doxorubicin—pancreatic cancer	6.13e-05	0.000136	CcSEcCtD
Alitretinoin—Abdominal pain—Doxorubicin—pancreatic cancer	6.13e-05	0.000136	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	6.12e-05	0.000365	CbGpPWpGaD
Alitretinoin—Asthenia—Epirubicin—pancreatic cancer	6.01e-05	0.000133	CcSEcCtD
Alitretinoin—RXRA—Metabolism—SLC2A2—pancreatic cancer	6e-05	0.000357	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	5.94e-05	0.000354	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—HSPA1A—pancreatic cancer	5.93e-05	0.000353	CbGpPWpGaD
Alitretinoin—Pruritus—Epirubicin—pancreatic cancer	5.93e-05	0.000131	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—TNF—pancreatic cancer	5.9e-05	0.000351	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MMP2—pancreatic cancer	5.89e-05	0.000351	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	5.87e-05	0.000349	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PTEN—pancreatic cancer	5.78e-05	0.000344	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PTEN—pancreatic cancer	5.78e-05	0.000344	CbGpPWpGaD
Alitretinoin—Diarrhoea—Epirubicin—pancreatic cancer	5.73e-05	0.000127	CcSEcCtD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.73e-05	0.000341	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Doxorubicin—pancreatic cancer	5.71e-05	0.000127	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	5.62e-05	0.000334	CbGpPWpGaD
Alitretinoin—Asthenia—Doxorubicin—pancreatic cancer	5.56e-05	0.000123	CcSEcCtD
Alitretinoin—Dizziness—Epirubicin—pancreatic cancer	5.54e-05	0.000123	CcSEcCtD
Alitretinoin—Pruritus—Doxorubicin—pancreatic cancer	5.49e-05	0.000122	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	5.42e-05	0.000323	CbGpPWpGaD
Alitretinoin—Vomiting—Epirubicin—pancreatic cancer	5.33e-05	0.000118	CcSEcCtD
Alitretinoin—Diarrhoea—Doxorubicin—pancreatic cancer	5.31e-05	0.000118	CcSEcCtD
Alitretinoin—Rash—Epirubicin—pancreatic cancer	5.28e-05	0.000117	CcSEcCtD
Alitretinoin—Dermatitis—Epirubicin—pancreatic cancer	5.28e-05	0.000117	CcSEcCtD
Alitretinoin—Headache—Epirubicin—pancreatic cancer	5.25e-05	0.000116	CcSEcCtD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.22e-05	0.000311	CbGpPWpGaD
Alitretinoin—Dizziness—Doxorubicin—pancreatic cancer	5.13e-05	0.000114	CcSEcCtD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	5.12e-05	0.000305	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	5.07e-05	0.000302	CbGpPWpGaD
Alitretinoin—Nausea—Epirubicin—pancreatic cancer	4.98e-05	0.00011	CcSEcCtD
Alitretinoin—Vomiting—Doxorubicin—pancreatic cancer	4.93e-05	0.000109	CcSEcCtD
Alitretinoin—Rash—Doxorubicin—pancreatic cancer	4.89e-05	0.000108	CcSEcCtD
Alitretinoin—Dermatitis—Doxorubicin—pancreatic cancer	4.88e-05	0.000108	CcSEcCtD
Alitretinoin—Headache—Doxorubicin—pancreatic cancer	4.86e-05	0.000108	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—SMAD4—pancreatic cancer	4.72e-05	0.000281	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CD44—pancreatic cancer	4.64e-05	0.000277	CbGpPWpGaD
Alitretinoin—Nausea—Doxorubicin—pancreatic cancer	4.61e-05	0.000102	CcSEcCtD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.55e-05	0.000271	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—CTNNB1—pancreatic cancer	4.52e-05	0.000269	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.51e-05	0.000268	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GCG—pancreatic cancer	4.45e-05	0.000265	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MMP9—pancreatic cancer	4.43e-05	0.000264	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	4.31e-05	0.000257	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PRSS1—pancreatic cancer	4.2e-05	0.00025	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—STK11—pancreatic cancer	4.19e-05	0.000249	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—MYC—pancreatic cancer	4.17e-05	0.000249	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—SRC—pancreatic cancer	4.08e-05	0.000243	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PIK3CA—pancreatic cancer	4.08e-05	0.000243	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PIK3CA—pancreatic cancer	4.08e-05	0.000243	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	4e-05	0.000238	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—VEGFA—pancreatic cancer	3.97e-05	0.000237	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—STAT3—pancreatic cancer	3.94e-05	0.000234	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.93e-05	0.000234	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—NRAS—pancreatic cancer	3.93e-05	0.000234	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	3.9e-05	0.000232	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—MYC—pancreatic cancer	3.89e-05	0.000231	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	3.86e-05	0.00023	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—MYC—pancreatic cancer	3.82e-05	0.000227	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	3.76e-05	0.000224	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—MYC—pancreatic cancer	3.74e-05	0.000223	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TGFB1—pancreatic cancer	3.65e-05	0.000217	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ARG2—pancreatic cancer	3.64e-05	0.000217	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—TYMS—pancreatic cancer	3.6e-05	0.000215	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—MYC—pancreatic cancer	3.59e-05	0.000214	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—MYC—pancreatic cancer	3.59e-05	0.000214	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—EGFR—pancreatic cancer	3.58e-05	0.000213	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	3.49e-05	0.000208	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—NOTCH1—pancreatic cancer	3.48e-05	0.000207	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TNF—pancreatic cancer	3.41e-05	0.000203	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	3.4e-05	0.000202	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—KRAS—pancreatic cancer	3.38e-05	0.000201	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PRSS1—pancreatic cancer	3.36e-05	0.0002	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—AKT1—pancreatic cancer	3.33e-05	0.000198	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—AKT1—pancreatic cancer	3.33e-05	0.000198	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PPARG—pancreatic cancer	3.28e-05	0.000195	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—TYMP—pancreatic cancer	3.19e-05	0.00019	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	3.13e-05	0.000186	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	3.12e-05	0.000186	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	3.06e-05	0.000182	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—APOE—pancreatic cancer	2.93e-05	0.000174	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	2.91e-05	0.000173	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ARG2—pancreatic cancer	2.91e-05	0.000173	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—AKT1—pancreatic cancer	2.89e-05	0.000172	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	2.89e-05	0.000172	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—HRAS—pancreatic cancer	2.87e-05	0.000171	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.77e-05	0.000165	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	2.65e-05	0.000158	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—AKT1—pancreatic cancer	2.65e-05	0.000158	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CG—pancreatic cancer	2.64e-05	0.000157	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—AKT1—pancreatic cancer	2.6e-05	0.000155	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GLP1R—pancreatic cancer	2.57e-05	0.000153	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	2.57e-05	0.000153	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PPARG—pancreatic cancer	2.55e-05	0.000152	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—TYMP—pancreatic cancer	2.54e-05	0.000151	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—AKT1—pancreatic cancer	2.54e-05	0.000151	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—DPYD—pancreatic cancer	2.53e-05	0.00015	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—AKT1—pancreatic cancer	2.49e-05	0.000148	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—AKT1—pancreatic cancer	2.49e-05	0.000148	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SLC2A2—pancreatic cancer	2.4e-05	0.000143	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CD—pancreatic cancer	2.32e-05	0.000138	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	2.17e-05	0.000129	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.1e-05	0.000125	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GLP1R—pancreatic cancer	2.05e-05	0.000122	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CB—pancreatic cancer	2.03e-05	0.000121	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—DPYD—pancreatic cancer	2.02e-05	0.00012	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTGS2—pancreatic cancer	2.01e-05	0.00012	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	1.91e-05	0.000114	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.89e-05	0.000113	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—MYC—pancreatic cancer	1.87e-05	0.000111	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CD44—pancreatic cancer	1.86e-05	0.000111	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.83e-05	0.000109	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GCG—pancreatic cancer	1.78e-05	0.000106	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTEN—pancreatic cancer	1.75e-05	0.000104	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—STK11—pancreatic cancer	1.67e-05	9.97e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.66e-05	9.92e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CD44—pancreatic cancer	1.48e-05	8.83e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.45e-05	8.64e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—TYMS—pancreatic cancer	1.44e-05	8.57e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.44e-05	8.56e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GCG—pancreatic cancer	1.42e-05	8.46e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—STK11—pancreatic cancer	1.34e-05	7.96e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—AKT1—pancreatic cancer	1.3e-05	7.73e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.25e-05	7.47e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CA—pancreatic cancer	1.23e-05	7.35e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—APOE—pancreatic cancer	1.17e-05	6.97e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—TYMS—pancreatic cancer	1.15e-05	6.84e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CG—pancreatic cancer	1.06e-05	6.29e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPARG—pancreatic cancer	1.02e-05	6.07e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—AKT1—pancreatic cancer	1.01e-05	6.01e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—APOE—pancreatic cancer	9.34e-06	5.57e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CD—pancreatic cancer	9.29e-06	5.53e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	8.85e-06	5.27e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	8.43e-06	5.02e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPARG—pancreatic cancer	8.14e-06	4.85e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CB—pancreatic cancer	8.09e-06	4.82e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTGS2—pancreatic cancer	8.02e-06	4.78e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	7.41e-06	4.42e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTEN—pancreatic cancer	6.99e-06	4.17e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	6.46e-06	3.85e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTGS2—pancreatic cancer	6.4e-06	3.81e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTEN—pancreatic cancer	5.58e-06	3.33e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CA—pancreatic cancer	4.93e-06	2.94e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—AKT1—pancreatic cancer	4.03e-06	2.4e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	3.94e-06	2.35e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—AKT1—pancreatic cancer	3.22e-06	1.92e-05	CbGpPWpGaD
